2m 2m 2m 2m 2m 2m 2m
SAVARA (SVRA)
NASDAQ
$4.83-$0.22 (-4.36%)
Price as of Oct 02, 2026 5:28 PM EDT- $1.0BMarket Cap
- 44.56%1-Year Change
- BiotechnologyIndustry
SAVARA (SVRA)
$4.83-$0.22 (-4.36%)
SVRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.04 | ||
Change | -$0.11 (-2.23%) | ||
Open | $5.15 | ||
High | $5.24 | ||
Low | $5.03 | ||
Previous Close | $5.16 | ||
Volume | 2,549,670 | ||
30-Day Average Volume | 1,939,016 | ||
1-Week Change | -0.49% | ||
1-Month Change | -5.70% | ||
1-Year Change | 44.56% | ||
3-Year Change | 33.47% | ||
5-Year Change | 276.49% | ||
Fundamentals | |||
Shares Outstanding | 205.5M | ||
Total Assets | $192.1M | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$40.2M | ||
Free Cash Flow | -$30.0M | ||
EBIT | -$40.2M | ||
EBITDA | -$40.2M | ||
Net Working Capital | $160.7M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -32 | ||
PEG | 5 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue